Overview
Investing.com’s AI‑driven stock‑picker highlighted a set of equities that posted outsized gains during the latest earnings season while broader U.S. indices (S&P 500, Dow, Russell 2000) were reaching all‑time highs. The article, dated 18‑08‑2026, emphasizes that disciplined, data‑backed selection is essential in a stretched market.
Monthly Top Performers
In the last month, NVE Corporation (NASDAQ:NVEC) surged 41.47%, Tenet Healthcare (NYSE:THC) rose 37.4%, Bausch Health (NYSE:BHC) climbed 34.8%, Insight Enterprises (NASDAQ:NSIT) advanced 33.8%, and Gartner (NYSE:IT) gained 29.2%.
NVE Corporation Details
NVE reported an 81% jump in Q1 total revenue to $11 million, driven by demand for medical devices, robotics, and industrial automation. Earnings per share increased from $0.74 a year earlier to $1.32. Management announced a $1.00 per‑share dividend and introduced next‑generation ultraminiature magnetic sensors. Peter Eames, a long‑tenured technology chief, was appointed CEO, ensuring leadership continuity. The company operates with a ~79% gross margin, ~60% operating margin, and recorded 27% quarterly net‑income growth. A dividend yield of roughly 3.8% and a doubled manufacturing footprint position it for accelerated growth into fiscal 2027, with expectations of a defense‑sector recovery. Zacks upgraded the stock to “Outperform” after the AI‑infrastructure spin‑tronics technology gained traction for AI data‑center energy efficiency.
Tenet Healthcare Details
Tenet posted Q2 adjusted EPS of $6.12 on quarterly revenue of $5.63 billion, beating consensus and prompting an uplift of full‑year EPS guidance to approximately $21. The USPI ambulatory‑care segment contributed about half of corporate profits and grew revenue ~14% quarter‑over‑quarter. Tenet generated $2.5 billion of annual free cash flow and delivered a 15% YoY EBITDA increase, enabling a $1 billion share‑buyback in Q2 and resulting in credit‑rating upgrades from both S&P and Moody’s. The stock had previously fallen ~21% on market jitters, trading roughly 40% below analyst fair‑value estimates of about $261. Net leverage was reduced to 2.25 × EBITDA.
Other Picks and Long‑Term Winners
Additional monthly winners included Bausch Health (+34.8%), Insight Enterprises (+33.8%) and Gartner (+29.2%). Stocks first selected earlier that continue to outperform are Delek US Energy (+78.52%), Everforth (+75.68%), Consensus Cloud Solutions (+72.47%), Nucor (+71.27%) and Haemonetics (+65.51%).
AI Model Track Record
Since its launch in November 2023, the AI system has delivered a cumulative return of +210.89%, outpacing the S&P 500 by +128.05%. The performance is based on monthly rebalancing of up to 20 high‑conviction stocks per strategy, with equal weighting across selections.
How the AI Picker Works
Each month the proprietary engine evaluates thousands of global equities using over 15 years of financial data across more than 150 quantitative models. It scores stocks on momentum, valuation, and business performance, selecting up to 20 candidates per strategy. The portfolio is rebalanced monthly: new opportunities are added, strong performers retained, and under‑performers removed. While investors may adjust allocations, the equal‑weight framework provides a transparent benchmark for assessing model efficacy.